Somatus uses a personalized, whole-person approach that leverages local care teams, predictive analytics, and advanced technology to delay disease progression, improve quality of life, and reduce total cost of care. The company achieved 100% customer and provider partner retention in 2024 and to date in 2025, reflecting accelerating demand for its integrated care model.
Cyborg Score Rationale
Somatus surpassed 500,000 patients under management in July 2025 and achieved extraordinary growth through customer expansions, new client launches, and broadening capabilities, managing over $14B in healthcare costs. Strong clinical validation, scale, market leadership position, and consistent retention offset pre-IPO valuation uncertainty.
Top Insights
In July 2025, Somatus surpassed 500,000 patients actively under management across all 50 states and DC, more than doubling the 275,000-patient milestone announced in October 2024.
The company contracts with 100+ nephrology practices and 5,500+ providers in value-based care partnerships and manages 1,500+ self-funded organizations.
In July 2024, Somatus became the first value-based kidney care and chronic condition management provider to achieve NCQA Accreditation for Health Equity.
Somatus has raised $478M in total funding across multiple rounds.
Named Competitors
Strive Health — Value-based kidney care management
Monogram Health — Home-based specialty care platform
Recent Developments
(July 2025) Surpassed 500,000 patients under management across all 50 states with $14B+ in medical expenses managed
(October 2025) Released study demonstrating 13% relative reduction in mortality for patients enrolled in Somatus care model
(July 2024) Achieved NCQA Accreditation for Health Equity, first provider in value-based kidney care segment to receive this distinction
Open the full interactive Somatus, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.